Validating your cold chain to meet and exceed increasingly stringent regulatory expectations in today’s global...
Houston-based biopharmaceutical cold chain validation engineering firm Modality Solutions is thrilled to declare it made the Houston Business Journal’s 2020 Fast 100 rankings of the city’s fastest-growing privately held companies for the second year in a row. Companies ranked by revenue growth from 2017 to 2019. The engineering firm moved up from No. 90 on the 2019 list to No. 62 on the 2020 list with 65% revenue growth.
“Amid the challenging business environment of Covid-19, the Houston Business Journal is proud to once again recognise the fastest-growing private companies in Houston,” said Bob Charlet, Publisher. HBJ announced in July the list of Fast 100 companies in alphabetical order, with the final rankings revealed during a live online broadcast September 18.
To qualify for the Fast 100, companies on the list must meet the following criteria:
- Be headquartered in the Houston area.
- Be for-profit and privately held.
- Been in operation for at least five full fiscal years and have earned at least $1 million in revenue in the latest fiscal year.
- Information for the Fast 100 list was obtained from questionnaires completed by company representatives and compiled by HBJ research.
Award-winning Modality Solutions also made the Inc. 5000 list two consecutive years. For 2020, it reported a three-year revenue growth of 71%. The Inc. 5000 list represents a unique look at the most successful companies within the American economy’s most dynamic segment–its independent small businesses. Modality Solutions was one of four engineering firms from the metro area and one of 11 in the State of Texas.
Co-founded in 2011 by Gary Hutchinson and Daniel J Littlefield, Modality Solutions is a global biopharmaceutical cold chain validation engineering firm. It supports fast-track regulatory approval for biologics and speciality therapies. As industry logistics network experts, it provides engineering services focused on the qualification of thermal packaging, the selection of monitoring & controls systems, the execution of transport validation, the design of controlled-environment logistics, and the operational support for clinical trials.
“Modality Solutions is pleased to be recognised for the second year in a row for our sustained managed growth in the Houston region,” said President Gary Hutchinson. “Our mission is to help our clients successfully launch new therapies and assist them in preparing for regulatory reviews. And I’m proud to say our team is made up of the brightest engineering professionals in biopharmaceutical cold chain logistics.”
For more information, please fill out the enquiry form attached to this page.
Last month, the FDA approved tafasitamab-cxix (official name Monjuvi®) in combination with Lenalidomide as a...
Immunomedics (www.immunomedics.com) is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment...
Covid-19 and the Race to Get a Vaccine Through FDA’s Supercharged Fast Track Approval Named Coronavirus Treatment Acceleration Program (CTAP)
The Coronavirus Treatment Acceleration Program launched by the FDA in response to Covid-19 is a...